Back

A polypill for cardiovascular disease prevention with a focus on non-alcohol steatohepatitis

European Heart Journal

15 February 2022
Organised by: Logo
Read full article
ESC Journals PREVENTIVE CARDIOLOGY Risk Factors and Prevention

Contributors

Philip Joseph
Philip Joseph

Author

McMaster University Hamilton , Canada

Salim Yusuf
Salim Yusuf

Author

You may be interested in
thumbnail
Congress Presentation
Antihypertensive drugs in experimental NAFLD as the first step to the establishment of criteria for choosing appropriate treatment of hypertension in NAFLD carriers
2 September 2019
thumbnail
Congress Presentation
Global cardiovascular health challenges - discussion
1 September 2025
thumbnail
Congress Presentation
Association of liver dysfunction with outcomes after percutaneous coronary intervention - a systematic review and meta-analysis
28 August 2023
thumbnail
Congress Presentation
An observational, international, cohort study to evaluate the satisfaction and preferences of patients in preventive treatment of secondary cardiovascular events with a cardiovascular polypill
3 September 2019

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources